Low Rates of Both Lipid-Lowering Therapy Use and Achievement of Low-Density Lipoprotein Cholesterol Targets in Individuals at High-Risk for Cardiovascular Disease across Europe

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

(2013)   LANCET

Trends in Low-Density Lipoprotein Cholesterol Goal Achievement in High Risk United States Adults: Longitudinal Findings from the 1999–2008 National Health and Nutrition Examination Surveys

(2013) Matthew C. Tattersall et al.   PLoS One

Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases

(2013) C. R. Dormuth et al.   BMJ-British Medical Journal

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

Evidence on the prevalence and geographic distribution of major cardiovascular risk factors in Italy

(2012) Roberta Laccetti et al.   PUBLIC HEALTH NUTRITION

Magnitud y manejo de la hipercolesterolemia en la población adulta de España, 2008-2010: el estudio ENRICA

(2012) Pilar Guallar-Castillón et al.   REVISTA ESPANOLA DE CARDIOLOGIA

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

(2011) et al.   EUROPEAN HEART JOURNAL

Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study

(2011) J. R. Banegas et al.   EUROPEAN HEART JOURNAL

Clinical Implications of the ACCORD Trial

(2011) S. Genuth et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Survey of physicians’ practices in the control of cardiovascular risk factors: the EURIKA study

(2011) Jean Dallongeville et al.   European Journal of Preventive Cardiology

Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA)

(2010) Fernando Rodríguez-Artalejo et al.   BMC PUBLIC HEALTH

Prevalence, treatment and control of dyslipidaemia in Switzerland: still a long way to go

(2010) Mathieu Firmann et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Prevalence of cardiovascular risk factors in an urban adult population from southern Spain. IMAP Study

(2010) R. Gomez-Huelgas et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators

(2009) Marie Therese Cooney et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION